AC Immune & Lilly Team Up Again to Stop Alzheimer’s with Brain-Targeting Drugs
AC Immune updates Eli Lilly deal to develop pill-based Tau drugs for Alzheimer’s, aiming to stop disease early with promising preclinical results.
NOTRELOAD AI
Bio-Rad Faces Headwinds as Citi Downgrades Shares to Neutral
Citi downgrades Bio-Rad to Neutral, citing weak chromatography growth and China market risks; price target cut to $300.
Bill Ackman Makes Bold €55 Billion Bid to Buy Universal Music Group
Bill Ackman offers $64B to buy Universal Music, shifting it to NY, aiming to fix issues, boost value, and back artists/tech.
Arm Faces Near-Term Risks as Morgan Stanley Turns Neutral
Morgan Stanley is neutral on Arm for now, raising its price target to $150 but warning growth may take time amid market risks.
Organogenesis’ PuraPly AM Shows Strong Success in Diabetic Foot Ulcer Trial
Organogenesis Holdings says PuraPly AM helps diabetic foot ulcers heal faster than standard care alone in a clinical trial.
Broadcom and Google Team Up to Power Anthropic’s AI Growth
Broadcom teams up with Google to supply custom AI chips through 2031 and provide Anthropic 3.5 gigawatts of computing power.